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 AIM OF THE STUDY 
To compare the effect of addition of two doses of clonidine (40µg and 
60µg) to 0.5% hyperbaric bupivacaine  2.75 ml, intrathecally  for sub 
umbilical surgeries .  
To evaluate : 
                           Time to onset of sensory and motor block 
                           Duration of sensory and motor block 
                           Duration of effective post operative analgesia 
                           Side effects 
 
 
 
 
 
 
                         
 INTRODUCTION 
Spinal anaesthesia  is commonly used for abdominal, perineal, 
gynaecological and lower limb operations. It offers excellent anaesthesia 
and  fewer side effects than  General anaesthesia .It is easy to perform  
and provides faster onset  and effective sensory and motor block. 
Bupivacaine produces  long lasting spinal anaesthesia   without  Transient 
neurological symptoms. Recently there  has been an interest in using  
additives to  intra thecal local  anasesthetics  to decrease  the dose of local 
anaesthetics   and also provide effective post operative  analgesia. 
Various studies have been conducted  to evaluate the addition of 
clonidine  to hyperbaric bupivacaine.   
 The alpha 2 adrenergic agonist  clonidine has a variety of actions 
including the ability to potentiate the effect of local anesthetics  .It 
prolongs sensory blockade and  also  reduces requirement of post 
operative analgesics. 
This study  was designed to evaluate  the addition of two doses of 
clonidine( 40 µg and 60µg) added to hyperbaric bupivacaine (0.5%)  
2.75ml  in  spinal anaesthesia for sub umbilical surgeries. 
 
 SPINAL ANAESTHESIA  AND ADJUVANTS 
Spinal (subarachnoid /intrathecal) anaesthesia is a form of central 
neuraxial block in which a temporary interruption of nerve transmission 
is achieved following injection of local anaesthetic and / adjuvant 
solutions into subarachnoid space. 
Subarachnoid block is one of the most commonly performed 
methods of regional anaesthesia. 
ANATOMY 
       The vertebral canal extends from foramen magnum to the sacral 
hiatus. Its boundaries are  the dorsal spine, pedicles and laminae of 
successive vertebrae( 7 cervical ,12 thoracic , 5 lumbar and 5 sacral) .The 
vertebrae are held together by overlapping ligaments namely, anterior & 
posterior longitudinal ligaments,ligamentum flavum, interspinous 
ligament ,supraspinous ligament and the intervertebral discs. 
The spinal cord a direct continuation of medulla oblongata begins 
at the upper border of atlas and terminates distally in the conus 
medullaris. The distal termination , because of the differential growth 
rates between the  bony vertebral canal and spinal cord   varies from L3 
in the infant to lower border of L1 in the adult. 
            Surrounding   the spinal cord in the bony vertebral column are 3 
membranes ( from within to periphery) : the pia mater , arachnoid mater 
and the dura mater.The piamater is a highly vascular membrane that 
closely invests the spinal cord.The arachnoid mater is a delicate non 
vascular membrane closely attached to outermost dura mater. 
STRUCTURES TO BE PIERCED FOR SUBARACHNOID BLOCK 
 
Between the 2 innermost membranes is the subarachnoid space . In 
this space , cerebrospinal fluid (CSF) ,spinal nerves , blood vessels that 
supply the spinal cord and dentate ligaments are present. Although the 
spinal cord ends at lower border of L1 in adults , the subarachnoid space 
continues upto S2.The outermost membrane in the spinal cord is the 
longitudinally organised fibroelastic membrane ,the dura mater. This 
 layer is the direct extension of cranial dura mater and extends as spinal 
duramater from foramen magnum to S2, where  filum terminale  blends 
with periosteum of subdural space which contains  small amounts of 
serous fluid to allow dura and arachnoid to move over each other. 
Surrounding the dura mater is the epidural space which extends 
from foramen magnum to sacral hiatus.Posterior to the epidural space is 
ligamentum flavum.Immediately posterior to the ligamentum flavum is 
interspinous ligament.Extending from external occipital protruberance to 
the coccyx ,posterior to this structure is the supraspinous ligament. 
          Lumbar puncture is routinely performed below L2 vertebrae down 
to the L5 –S1 interspace to avoid damage to the spinal cord which ends at 
lower border of L1 vertebra in adults. 
  
DIAGRAM OF DERMATOMES 
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 PHYSIOLOGY OF SUBARACHNOID BLOCK 
CEREBROSPINAL FLUID 
The cerebrospinal fluid is an ultrafiltrate of  blood plasma which is 
in hydrostatic and osmotic equilibrium.It is clear , colourless fluid found 
in spinal and cranial subarachnoid space and in ventricles of brain . The 
average volume in adults ranges from 120 to 150ml of which 35ml in the 
ventricles , 25ml is in the cerebral subarachnoid space and 75ml is in the 
spinal subarachnoid space.It is secreted by choroid plexus at a rate of 0.3 
-0.4ml/minute. 
PHYSICAL CHARACTERISTICS  OF CEREBROSPINAL FLIUD 
pH                                                7.4 
Specific gravity                           1.007 
Density                                        1.0003 
Baricity                                        1.000 
Pressure                         8-12 mmHg /  70- 80 cmH20 
Cells                                              3- 5 /cu.mm 
Proteins                                       20mg/dl 
Glucose                                        45 -80 mg/dl       
             The cerebrospinal fluid plays an important role in spinal 
anaesthesia as a media for dispersion of the local anaesthetic drug to the 
spinal nerve. An important factor determining the spread of drugs in 
subarachnoid space is specific gravity of the injected solution compared 
with that of CSF. 
MECHANISM OF SPINAL ANAESTHESIA 
      Injection of local anaesthetics into the spinal CSF allows access to 
sites of action both within the spinal cord and the peripheral nerve roots. 
The nerve roots leaving the spinal canal are not covered by epineurium 
and are readily exposed to the local anaesthetic within CSF. Therefore 
afferent impulses leaving via ventral nerve roots are blocked  during 
spinal anaesthesia . Spinal local anaesthetics block sodium channels and 
electrical conduction in spinal nerve roots. Local anaesthetics can exert 
sodium channel block within the dorsal and ventral horns  inhibiting the 
generation and propagation of electrical activity. 
The order in  which nerve fibres are blocked in spinal anaesthesia 
is preganglionic sympathetic B fibres followed by temperature fibres ( 
cold before warmth) , fibres carrying pin prick sensation , touch, deep 
pressure  and finally proprioception. Recovery is in the reverse order. 
 The major factors  determining the level of blockade after 
subarachnoid block are  the baricity of the local anaesthetic solution, the 
position of the patient before and after injection  and dose of the 
anaesthetic injected. 
FATE OF LOCAL ANAESTHETICS IN SUBARACHNOID SPACE 
Following injection of local anesthetic solution into subarachnoid 
space ,its concentration falls rapidly. The initial steep fall is due to mixing 
with CSF  and subsequent absorption into nerve roots and spinal cord. 
Depending on the type of drug used , it is metabolized in plasma by 
pseudocholinesterase or in the liver. The addition of a vasopressor to the 
local anesthetic will retard the absorption of the drug and thus increase 
the duration of anaesthesia. 
Indications for subarachnoid block 
Spinal anaesthesia  can be administered whenever a surgical 
procedure can be done with a sensory level of anaesthesia that does not 
produce adverse patient outcome  which includes, 
‐ Lower abdominal surgeries 
‐ Lower limb surgeries 
‐ Urological  procedures 
 ‐ Obstetric & gynaecological procedures 
- Perineal and rectal surgeries 
Contra indications for subarachnoid block 
An absolute contraindication for subarachnoid block is patient 
refusal . 
Other contraindications are : 
‐ Local sepsis 
‐ Uncorrected coagulopathy 
‐ Uncontrolled blood loss / shock 
‐ Fixed cardiac output states 
‐ Documented allergy to local  anaestehtics 
‐ Raised intracranial pressure 
‐ Neurological disease 
‐ Major spine deformities /previous surgery on the spine 
‐ Severe cardiac disease. 
SPINAL ANAESTHESIA TECHNIQUE 
The first step in successful application of spinal anaesthesia is 
proper patient selection. This is accomplished by  pre- anaesthetic 
evaluation of the patient through history, physical examination 
,laboratory data  and communication with patient   and surgical staff 
about details of the procedure. Reliable intravenous access through a 
 large bore intravenous canula( 18G /16G) is mandatory. Preloading  
limits  the hypotension that may result from sympathetic block. The 
recommended standards for airway management  and emergency drugs  
are kept in readiness.  
PROCEDURE 
PREPARATION  
Preparation of equipment and drugs is essential for performing a 
subarachnoid block. The choice of drug is based on duration of block 
desired, the surgical procedure and  patient variables. Spinal needles of 
various diameters with various types of points  are available.Spinal 
needles fall into two main categories: those that cut the dura and those 
that are designed to separate the dural fibres.The former includes the 
Quincke –Babcock needle and the latter include  the Greene , Whitacre 
and Sprotte needles. In order to keep the incidence of post dural puncture 
headache to a minimum , small bore needles with a  rounded non –cutting 
bevel are preferred.  
 
 
 
 SPINAL NEEDLES 
 
Position 
The choice of position of the patient for performing the 
subarachnoid block depends on a number of factors- the proposed surgery  
being the most important .  
  
LATERAL DECUBITUS POSITION 
           
 
          
In the lateral decubitus position, the patient is placed with back 
parallel to the edge of the operating table nearest the anaesthesiologist 
with thigh flexed upon the abdomen and neck flexed 
 
 
 SITTING POSITION 
.  
The sitting position is chosen when low lumbar and sacral levels of 
anaesthesia  are adequate for the surgical procedure or when obesity  or 
scoliosis makes identification of midline anatomy difficult  in lateral 
decubitus position  or when orthopaedic   problems of hip and knee exist. 
Projection & Puncture  
      The spinal puncture can be performed either by a midline or a 
paramedian approach ,usually at the L2 –L3, L3-L4, L4-L5 interspaces. 
The procedure is carried out under strict aseptic conditions.The patients 
 back is prepared with an antiseptic solution and sterile drapes are 
applied.A line from the highest point of iliac crest paases through  either 
spinous process of L4 or the L4-L5 interspace. The midline approach 
with the patient in sitting position /right lateral decubitus position is used 
in our study. Depending on the interspace and approach selected, 
subcutaneous skin wheal is raised over the intended puncture site  with 
local anaesthetic solution. The needle is inserted in the middle of the 
interspace with bevel parallel to the longitudinal dural fibres. After 
traversing the skin and subcutaneous tissue , the needle is advanced in a 
slightly cephalad direction with the long axis  of the vertebral column. 
The stylet is removed and appearance of cerebrospinal fliud  at the hub of 
the needle confirms correct position of the needle tip.Stylet is reinserted 
to prevent excess leakage of CSF.The hub of the needle is firmly held 
between the thumb and index finger of the anaesthesiologist’s non 
dominant  hand  and back of hand held against patients back to steady the 
needle , while syringe containing anaesthetic solution is firmly attached 
to the needle. 
After confirming   free flow of spinal fluid by aspiration, the 
anaesthetic solution is injected. The patient is placed in supine position. 
Cardiovascular and respiratory functions are monitored. Analgesia is 
 checked by loss of sensation to pin prick.Motor block assessed by 
modified Bromage score  . 
In the recent past various additives have been added to local 
anaesthetic solution – vasopressors, alpha 2 adrenergic agonists and  
acetyl choline esterase inhibitors. These produce prolongation of  
analgesia after  subarachnoid block and  reduce the dose requirement of 
local anaesthetics. 
COMPLICATIONS OF SUB ARACHNOID BLOCK 
Immediate 
1. Hypotension 
2. Bradycardia 
3. Toxicity due to intravascular injection 
4. Allergy to local anaesthetic 
5. Hypoventilation ( brainstem hypoxia) 
Late 
1. Post dural puncture headache 
2. Retention of urine 
3. Backache 
4. Meningitis 
5. Transient lesions of cauda equina 
6. Sixth nerve palsy 
7. Anterior spinal artery syndrome 
 PHARMACOLOGY OF BUPIVACAINE 
Bupivacaine is an amide local anaesthetic synthesised by 
A.F.Ekenstam  in 1957  and brought into clinical use in 1963. 
It is produced for clinical use in a racemic mixture containing equal 
proportions of the ‘S’  and ‘R’  enantiomers. It is supplied  for clinical use 
as hydrochloride salt. 
Chemical structure 
       Description : + 1- butyl –N- (2,6-dimethylphenyl)-2-piperidine 
Decarboxamide Hydrochloride monohydrate. 
                               BUPIVACANE    HYDROCHLORIDE 
 
 Physico-chemical profile 
Molecular weight (base)                            -  288 
pKa                                                            - 8.1 
Solubility In  
alcohol                                                        -   1  in 8 
water                                                          -    1  in 25 
octanol/water partition coefficient          -     high 
lipid solubility                                                -     28 
plasma protein binding                                -      95%                     
Mechanism of action  
Bupivacaine exerts its effect by inhibition of sodium channels. It 
acts to block conduction in nerves by decreasing or preventing the large 
transient increases in permeability of cell membrane to sodium ions that 
follows depolarisation of the membrane. Bupivacaine also reduces the 
permeability of the resting nerve membrane to potassium as well as 
sodium ions. 
Pharmacodynamics 
Bupivacaine by virtue of its pharmacological effects has a 
stabilizing action on all excitable membranes. The clinical profile of 
nerve blockade produced by bupivacaine differs from that of lignocaine. 
 It is 4 times more potent than lignocaine, but the onset of action is slower. 
The duration of action is considerably longer. The sensory block 
produced by bupivacaine tends to be more marked than the motor block. 
Pharmacokinetics 
Bupivacaine is rapidly absorbed from the site of injection. The rate 
of rise in plasma bupivacaine concentration and the peak plasma  
concentrations  depend on the route of administration. There is also some 
interindividual variation and peak systemic concentrations may occur 5  
and 30 mins after administration. The addition  of vasoconstrictor  delays 
absorption and results in lower plasma concentrations of bupivacaine. 
Pharmacokinetic profile 6 
Volume of distribution at stedy state (Vdss)        72  litres 
Clearance                                                                  0.47L/min 
t1/2α                                                                          2.7 min 
t1/2β                                                                          28min 
t1/2 γ                                                                         3.5hrs 
Metabolism 
Possible pathways for metabolism of bupivacaine include aromatic 
hydroxylation , N dealkylation , amide hydrolysis and conjugation. Only 
the N–dealkylated metabolic N –desmethyl bupivacaine has been 
 measured in blood and urine  after epidural and spinal administration. The 
degradation of bupivacaine takes place in the liver. Renal disease is 
unlikely to alter the kinetics of bupivacaine to any great extent.Less than 
10%  of the drug is excerted unchanged in urine6. 
Clinical applications : 
- Infiltration anaesthesia 
-  Peripheral nerve blocks 
- Central neuraxial blocks ( intrathecal, epidural, caudal) 
Contraindications  
- Paracervical block (in obstetrics) 
- Known hypersensitivity to amide local anaesthetics  
- Intra venous regional  anaesthesia (IVRA) 
 
Preparations available: 
 
0.25%  ,0.5%  solutions in 10ml and  20ml  vials 
5mg/ml (0.5%)bupivacaine and 80mg dextrose in 4ml ampoules for 
intrathecal injection (baricity  1.0207) 
 Recommended  safe dose 
Concentration used Max   permitted dose 
0.125%  - 0.5 % 3mg/kg  body weight 
0.75%( not to be used in obstetric 
epidurals) 
Max over 4 hrs -  150mg 
Max during  24hrs -4000mg 
0.5% plain/hyperbaric(intrathecal use)   20mg 
 
Adverse reactions 
Adverse reactions are associated with excess plasma levels of the 
drug  which may be due to overdosage, unintentional intravascular 
injection or slow metabolic degradation. 
CNS Reactions  
Excitation  characterised by restlessness,  anxiety, dizziness, 
tinnitus, blurred vision or tremors  possibly proceeding to convulsions, 
followed by drowsiness unconsciousness and cardiac arrest. 
CVS  
Part of the  blockade that occurs from  high plasma concentrations 
of bupivacaine occurs because of blockade of cardiac  sodium channels. 
Accidental intravenous injection of bupivacaine causes cardiac 
 dysarrythmias, atrioventricular block, refractory ventricular tachycardia  
and ventricular fibrillation.pregnancy increases the sensitivity of  
cardiotoxic effects of bupivacaine. 
Bupivacaine  binds and inhibits  cardiac voltage gated calcium and 
potassium channels at concentrations greater than those at which binding 
to  sodium  channel is maximal. 
Unlike other local anaesthetics ,bupivacaine dissociates from 
blocked sodium channels at a much slower rate , resulting in prolongation 
of maximal rate of depolarization (Vmax) and  creating the potential for 
re entrant type of ventricular arrhythmias. 
Allergic reactions 
Manifests as urticaria, pruritis,angioneurotic edema  etc. Cross 
sensitivity among members of amide local anaesthetics has been reported. 
 
 
 
 
 
 PHARMACOLOGY OF CLONIDINE  HYDROCHLORIDE  
Clonidine a imidazoline derivative is a selective partial agonist for 
alpha 2 adrenergic receptors.It is known to increase  sensory and motor 
block of local anaesthetics. 
Its action is mediated spinally through activation of post synaptic 
alpha 2 receptors in the substantia gelatinosa of spinal cord. 
STRUCTURE OF CLONIDINE 
                          
Physical chemistry  
C9H9N3CI2HCL 
2,6 DichloroN-2 imidazolidinyiedlenebenzenamine : hydrochloride 
                                            
 1. Molecular weight(freebase)                           266.6(230.1) 
2. pKa                                                                 8.05 
3. Solubility in alcohol                                       1 in 25 
4. Solubility in water                                          1 in 13 
5. Octanol/water partition co efficient               3.02 
Clonidine hydrochloride is a white crystalline, odourless powder   
with a bitter taste. It is produced by chemical synthesis. 
Pharmacology 
Clonidine is a partial agonist at alpha adreno receptors both within 
the central nervous system and in the periphery. It is more specific for 
alpha 2 than for alpha 1 with a ratio of affinities at these sites at 
approximately 300:1.Within the CNS  alpha 2 adrenoreceptors are located 
both presynaptically on terminals of neurons which release a variety of 
transmitters( nor epinephrine ,epinephrine, serotonin and acetylcholine) 
and post synaptically on  noradrenergic neurons. 
Mechanism of clonidine as an adjuvant in central neuraxial blockade 
Intrathecal clonidine increases the duration of both sensory and 
motor block.The mechanism of  clonidine induced potentiation of sensory 
block  in spinal anaesthesia is  mediated by presynaptic ( inhibition of 
transmitter release )  and post synaptic  ( enhancing hyperpolarisation) 
 The reason for potentiation of motor block seems to be 
hyperpolarisation of ventral horn neurons of spinal cord .This is  dose 
related21. 
Clonidine  blocks conduction  of C and A delta fibres  and 
increases potassium conductance  in neurons and also intensifies  
conduction block of local anaesthetics. Clonidine may cause local 
vasoconstriction12. 
EFFECTS ON ORGAN SYSTEMS 
Cardiovascular System 
Oral or intra venous administration of clonidine causes a dose 
dependent fall in  blood pressure and heart rate in both supine and erect 
position , with the orthostatic response being most prominent 
Clonidine affects blood pressure in a complex fashion.In nucleus 
tractus solitarius  and locus ceruleus of brain stem  activation of post 
synaptic alpha 2 adrenoreceptors reduces sympathetic drive.In addition it 
activates noradrenergic binding sites in  lateral reticular nucleus  thereby 
producing hypotension and  antiarrythmogenic action.The magnitude of 
hypotensive effect is greater in hypertensive than in normotensive 
subjects12. 
 The brainstem and  peripheral effects of alpha 2 adrenoreceptor 
stimulation are counter balanced by direct  peripheral  vasoconstriction  
from circulating  concentrations of  clonidine.  As a result the dose 
response for clonidine by  neuraxial or systemic administration is U 
shaped, with peripheral vasoconstriction from circulating drug 
concentrations  at high doses opposing central sympatholysis. 
Neuraxial administration of clonidine  directly inhibits sympathetic 
preganglionic neurons  in spinal cord.  Degree of hypotension is related to 
spinal level of injection.  
The pressor effect of high dose of clonidine  is due to peripheral  
vasoconstriction mediated by stimulation of post synaptic alpha 1 and or 
alpha 2 adrenoreceptors on vascular smooth muscle21. 
RESPIRATORY SYSTEM 
The respiratory depressant effect of clonidine is not remarkable 
unless massive doses are given.The effect of clonidine is less potent than 
that of opiate narcotics23. 
CENTRAL   NERVOUS SYSTEM20 
Sedation is one of the most consistent effects mediated by central  
alpha 2 receptors. The locus ceruleus  was shown to be the principal 
 region responsible for sedative effect. Another characteristic effect of 
alpha 2 agonists is anxiolysis which is comparable to the response 
produced by benzodiazepine compounds. 
  Clonidine has a potent analgesic action that cannot be reversed by 
naloxone, an opioid antagonist, indicating that clonidine and opioid  
mediate analgesia through independent recptor mechanism.Clonidine 
may potentiate the effects of bupivacaine by reducing spinal cord blood 
flow  and prolonging  the effective availability of bupivacaine. 
            There  is a 50%  decrease in MAC of inhalational anesthetics and 
decreased  anaesthetic  requirements of opioids. At doses of 75µg iv, it 
prevents shivering.clonidine is also effective in suppressing signs and 
symptoms of  withdrawal from opioids ,benzodiazepines and ethanol. 
ENDOCRINE 
Endocrine and metabolic effects mediated by alpha2 
adrenoreceptor stimulation are 1. Increased TSH and GH secretion 
2.Decreased  ACTH and ADH  secretion and 3.Inhibition of glucose 
stimulated insulin release , but this does not result in severe 
hyperglycemia in a clinical setting. 
 GIT 
Stimulation by clonidine of peripheral presynaptic alpha2 
adrenoreceptors  on post ganglionic  noradrenergic  or cholinergic 
neurons  contributes to reduced salivary flow, intestinal motor  activity  
and gastric acid secretion. 
Pharmacokinetics 
Oral absorption                                             100% 
Pre systemic metabolism                             0- 25% 
Elimination half life                                       20 -25h 
Volume of distribution                                 2L /kg 
Plasma protein binding                                 20 -40% 
Clonidine is approximately  60%  excreted unchanged in urine. The 
remaining 40% elimination is by oxidative metabolism predominantly in 
the liver .There is no evidence that any metabolites possess significant 
biological activity. Clearance of clonidine is linearly related to dose over 
75 – 300mcg. Total plasma clearance is 3ml/kg/min, while  renal 
clearance accounts for 1.8ml/kg. Clearance may be reduced in the 
presence of abnormal renal functions. Although clonidine may cross the 
placenta it does not appear to reach concentrations sufficient to affect the  
fetus. 
 METABOLISM 
Clonidine is approximately  cleared by metabolism predominantly 
in the liver to five inactive metabolites.the predominant  pathways are: 
hydroxylation of the phenyl ring ,and opening up of the imidazoline ring  
following an initial reductive step  with subsequent oxidative  cleavage. 
The hydroxylated metabolites are subjected to secondary conjugation 
with sulphate or glucoronide prior  to  urinary excretion.             
DOSAGE  OF CLONIDINE IN  VARIOUS ROUTES 
S.No. Route Bolus Cont infusion 
1 Oral 4- 5mcg/kg  
2 IM 2mcg/kg  
3 IV 4- 5mcg/kg  
4 Epidural 75- 450mcg 12.5 – 70mcg/hr
5 Intrathecal 30- 225mcg 8 -400 mcg/day 
     
USAGE  
1. Antihypertensive agent 
2. Anaesthesia -prolongation of action of local anaesthetic  after 
 neuraxial administration ,pre- medication  and post anaesthetic 
 shivering 
3. Opiate withdrawal syndrome 
4. Glaucoma ( apraclonidine and brimonidine) 
 5. Migraine prophylaxis 
6. Provocative tests of growth hormone secretion, in the  
 investigation of short stature 
7. Diagnosis of phaeochromocytoma 
8. Psychiatric disorders 
9. Menopausal symptoms 
10. Chronic diarrhoea. 
CONTRAINDICATIONS 
Disorders of cardiac impulse generation and conduction like Sino 
atrial disease ( sick sinus syndrome) , Atrioventricular node disease  and 
patients with cardiac pacemakers. 
ADVERSE REACTIONS 
Common symptomatic effects are  sedation (35- 100%) , dry mouth 
(25 – 90%), bradycardia, constipation  and contact dermatitis( 
transdermal clonidine) .Less common effects include postural 
hypotension, dizziness, fluid retention ( weight gain , oedema), sleep 
disturbances (insomnia, sleep reversal, nightmares, hallucinations, 
reduction of REM sleep ), impotence ,parotid swelling  and depression. 
Uncommon effects are rash, pruritis, angioedema, hepatitis, 
 gynecomastia, raynauds phenomenon, thinning of hair, urinary retention  
and agitation. 
Withdrawal syndrome which is characterised by a rapid rise in 
blood pressure, with marked blood pressure lability, symptoms such as 
headache, flushing , sweating , insomnia , agitations, emotional lability , 
tremor .nausea and vomiting presents 18- 72 h after the last dose of 
clonidine. The syndrome can be prevented by gradual withdrawal of 
clonidine  over  days to weeks and , if present controlled by reintroducing  
clonidine  treatment  or by inhibiting peripheral sympathetic nervous 
activity, with alpha and beta adrenoreceptor antagonists. 
Disturbance of cardiac impulse generation and conduction in the 
presence of pre existing SA and AV node disease can lead to 
symptomatic bradycardia  and impairment of atrio ventricular (AV ) 
nodal conduction (wenkebach phenomenon , AV dissociation )  which 
have been occasionally described. 
PREPARATIONS 
Oral forms 
1. Catapres tablets (Boehringer Ingelheim UK) containing clonidine 
 hydrochloride 100mcg, 200mcg or 300mcg. 
 2. Dixarit tablets (Boehringer Ingelheim ,UK) containing clonidine 
 hydrochloride 25 mcg. 
Transdermal form 
Catapres TTS delivering clonidine 100mcg , 200mcg , or 300mcg 
daily for 1 week 
Parenteral form 
1. Catapres injection (Boehringer Ingelheim, UK) containing 
 clonidine hydrochloride 150mcg/ml ampoules 
2. CLONEON (Neon labs ltd, thane) containing clonidine 
 hydrochloride 150 mcg /ml ampoule. 
 ASSESSMENT OF  BLOCKADE AFTER SPINAL ANAESTHESIA 
Following subarachnoid block  assessment of motor & sensory  
block is done in the following manner. 
SENSORY BLOCK 
      Sensory block was assessed by loss of sensation to pinprick using 
23G sterile needle. The assessment was started immediately after 
injection and continued every 15 secs till loss of pinprick sensation  at L2 
level. Onset of sensory block was taken as time from intrathecal injection 
to loss of pinprick sensation at L2. At 20mins  interval after SAB , the 
dermatomal level of sensory block noted and this was considered as 
maximum level of sensory block. 
MOTOR BLOCK 
    Motor block was assessed using modified BROMAGE score 
Grade 1 : free movement of legs and feet 
Grede 2 : just able to flex knees with free movement of feet 
Grade 3 : unable to flex knees but with free movement of feet 
Grade 4 : unable to move legs and feet      
 Assessment of motor block was started immediately after the 
intrathecal injection. It was tested every 15 secs till BROMAGE SCORE 
of 1 was reached. Onset of motor block was taken as time taken to 
achieve BROMAGE score of 1 from Subarachnoid block.The degree of 
motor block after 20mins of injection was noted and this was considered 
maximum degree of motor block.Thereafter motor block regression was 
noted and duration of motor block was taken as time from SA injection to 
return of BROMAGE score to 1 
ASSESMENT OF SEDATION AND PAIN : 
Sedation was assessed using Ramsay sedation score and pain was 
assessed using  visual analogue scale.  
Level 1 : Anxious And agitated ,or restless or both 
Level 2 : Co Operative , oriented and tranquil 
Level 3 : Responds to commands only 
Level 4 : Brisk response 
Level 5 : Sluggish response 
Level 6 : No Response. 
  
Pain was assessed using visual analogue scale. 
 
 REVIEW OF LITERATURE 
Clonidine combined with local anaesthetics in spinal anaesthesia:  
van  tuiijl et al34  investigated the effect of addition of clonidine to 
hyperbaric bupivacaine  on post operative morphine consumption  after 
caessarian section . 
A group of 106 patients were randomly allocated to receive spinal 
anaesthesia with either 2.2ml of 0.5%bupivacaine heavy with 0.5ml NS 
0.9% total 2.7ml  (Gp B)   or to receive 2.2ml of 0.5% bupivacaine heavy 
with  clonidine 0.5ml – 75µg  diluted in 0.9% NS total of 2.7ml (Gp 
BC).The time for first analgesic request  was 129 mins  in the BC gp 
compared to 55mins in the B gp.In the BC gp 58% had a MAP < 70 
mmHg  compared to 9% in gp B. Clonidine added to bupivacaine in 
caessarian section prolongs the duration of analgesia and motor block  .It 
did not result in reduced morphine consumption in the first post operative 
day. 
Wu CI et al32  studied the  effect of adding clonidine to hyperbaric   
tetracaine spinal anaesthesia in 60 ASA class I -  II patients .The subjects 
were randomly allotted to 4 groups.All patients received  tetracaine 10mg 
in 10% glucose solution 2 ml. Patients in group I received  the above 
medication and were the control group, patients in other group received 
 tetracaine plus increasing doses  of clonidine : 15 µg(gp 2) ,30µg (gp 3) 
and 45µg(gp 4).The three clonidine groups had significant increase in 
sensory regression time to L1 level( by 42 ,47 , 60% respectively), and 
also had significantly increased motor complete recovery  time , but the 
incidence of hypotension and bradycardia  was increased in clonidine 
45µg  group.He concluded that addition of 15µg or 30µg  may be useful 
as a means of increasing the duration of hyperbaric tetracaine spinal 
anaesthesia. 
NIEMI29 studied the analgesic and circulatory effects of intrathecal 
clonidine in patients undergoing knee arthroscopy under spinal 
anaesthesia.Forty ASA I & II patients were randomly divided into 2 
group. One group received clonidine 3 µg /kg mixed with 0.5% 
bupivacaine  and the other group  an identical saline volume mixed with 
bupivacaine  as above in a double blinded fashion.Oxycodone 0.14mg/kg  
i.m or ketoprofen 100mg p.o  was administered when needed. The 
duration of sensory analgesia, was longer in clonidine group (mean 215 
mins) than in control group ( mean 160 mins) (p<0.05) . Duration of 
motor blockade  was also longer in clonidine group ( mean 161mins) 
(p<0.05).Mean arterial pressure  and heart rate  were significantly lower 
in the clonidine group compared to control group.More patients in the 
 clonidine group were sedated 3 – 6 hrs after the injection ( p<0.05). 
Addition of clonidine prolonged the bupivacaine spinal block. 
De Negri P et al10  studied to determine whether intrathecal 
administration of clonidine can reduce the dose  of local anesthetic , and 
the effects of clonidine on cardiovascular system  and on arousal level.In 
56 patients  scheduled for minor surgical procedure (spermatic vein 
ligature) under unilateral spinal anesthesia  with hyperbaric bupivacaine 
1% one half of patients received clonidine 150µg in addition to 
bupivacaine .Cardiac output ,stroke volume ,ejection fraction  were 
measured by thoracic electric bio impedance method, baseline and until 1 
hr after surgery. In clonidine treated group, variations of cardiovascular 
parameters were observed, In the same group sensory block , motor block 
were significantly prolonged.  A higher sedation level  and a significant 
post operative  analgesia were also observed.The addition of clonidine to 
hyperbaric bupivacaine  seems to be particularly useful in unilateral 
spinal anesthesia, exerting minimal influence on hemodynamic 
parameters  and guaranteeing  a satisfactory postoperative analgesia. 
Seah ys et al31 studied the prolongation of analgesic effect of 
hyperbaric bupivacaine spinal anestehsia with clonidine . 40 AS A class I 
& II patients  scheduled for TURP  were randomly classified into 2 
 groups pof 20 each. In the saline group, 3ml of 0.5% hyperbaric 
bupivacaine + 1ml NS  was given. In the clonidine group, 1ml of (150µg) 
clonidine in addition to 3ml of 0.5% bupivacaine was given. The mean 
time for  two segment regression to L2  were significantly  greater in 
clonidine group than in the saline group .Motor block was also prolonged 
in the  clonidine group than in the saline group. Side effects such as 
hypotension  and bradycardia commonly occurred in clonidine group , 
but all patients could be effectively treated with ephedrine and atropine 
respectively. 
Clonidine as sole analgesic in spinal anaesthesia 
 Filos kriton14 et al studied to evaluate the effect of intrathecal 
clonidine as the sole analgesic on pain following caessarian section. 
Twenty patients  who underwent elective caessarian section receive 45 
mins after GA either 150µg  clonidine(n=10) or saline (n=10) 
intrathecally.Pain scores were lower in clonidine than saline treated 
patients .Pain relief in terms of the first supplemental analgesic  requested 
by patients lasted 414 mins after clonidine  and 181 mins after saline. The 
results suggest that 150µg clonidine is effective in pain following 
caessarian section but is not free of side effects like hypotension, sedation 
and dryness of mouth. 
 Goudas Leonidas et al19  studied to  evaluate the dose response 
hemodynamics  and analgesic profiles of intrathecal clonidine .30 women 
who underwent LSCS  under GA   45 mins after tracheal extubation,  a 
lumbar puncture was performed and patients received 150µg (gp 1) 
,300µg( gp 2) and 450µg (gp 3) clonidine. Pain relief lasted 402  ±75 
mins in group 1,570± 76 mins in gp 2 , 864±  80 mins in gp 3 . Sedation 
was found in all three groups. The results demonstrated dose dependent 
analgesia  after intrathecal clonidine at doses as great as 450 µg .A  
relative hemodynamic stability  is observed  suggesting a pressor effect at 
peripheral sites. 
Clonidine combined with opioids and local anesthetics in spinal 
anesthesia  
Chiari astrid et al7 evaluated the dose response potency of 
intrathecally administered clonidine during 1st stage of labour along with 
sufentanil . 36 parturients  received 50µg, 100 µg and 200 µg of 
intrathecal clonidine.  
The duration of analgesia was significantly more in 200µg gp. 
Duration and quality of analgesia were more pronounced in 100µg, 
200µg  gps than with 50µg gp. The high incidence of hypotension 
requires caution with use of 200µg for labour analgesia. 
 Gautier Philippe E et al20 studied the efficacy of low doses of 
intrathecal clonidine  (15 µg & 30 µg )combined with sufentanil . 93 
parturients received one of the following intrathecal solutions, either 15 
µg clonidine (n=10), 30µg clonidine (n=10), 2.5µg sufentanil & 15 µg 
clonidine( n=13), and  5 µg ufentanil  with 30 µg clonidine (n=13). 
Patients receiving 30 µg intrathecal clonidine with 2.5 or 5 µg sufentanil 
had significantly long lasting analgesia .30 µg intrathecal clonidine with 
2.5 or 5 µg  intrathecal sufentanil had significantly increased the duration 
of  analgesia during the first stage of labour without adverse maternal or 
fetal effects. 
Benhamou Dan et al2 studied 78 pregnant women at term 
scheduled for elective caessarian section to compare the analgesic 
efficacy and side effect profile of a spinal block with hyperbaric 
bupivacaine  alone (group B)  or  combined with 75 µg  clonidine (group 
BC) or with clonidine 75 µg and fentanyl 12.5 µg (group BCF) . Adding 
a small dose of intrathecal clonidine  to bupivacaine increases the quality 
of intraoperative analgesia and decreases pain during cesarian section . 
Combining clonidine with fentanyl further improved  analgesia. 
Acalovschi lurie et al1 studied the effects of intrathecally 
administerd epinephrine and clonidine on the duration and quality of 
 meperidine spinal block. 45 patients scheduled for orthopaedic surgery 
divided into 3 groups, received spinal anaesthesia with 1mg/kg  
meperidine 5% alone  or with 200 µg  epinephrine or 2 µg /kg clonidine.  
 The duration and degree of motor block were increased by 
addition of both epinephrine and clonidine. A tendency toward 
bradycardia  and decrease in  MAP was potentiated by clonidine.  The co 
administration of clonidine or epinephrine  with meperidine  enhances the 
duration and degree of spinal anaesthesia  and that adding clonidine 
prolongs duration of post operative analgesia. 
Owen MD et al30  studied to determine  whether the addition of 
clonidine and neostigmine to intrathecal bupivacine fentanyl would 
increase the duration of analgesia without increasing side effects for 
patients in labour.45 healthy parturients  in active labour received 2ml  
intrathecal dose of one of the following dextrose containing solutions : 1. 
Bupivacaine 2.5mg and fentanyl 25 µg (BF)  2. BF + Clonidine  30 µg.  
3. BFC + neostigmine 10 µg( BFCN). Patients administered BFCN had 
significantly  longer analgesia (165 ± 32  mins ) than those who received 
BF (90 ±21mins)  or BFC (123±21 mins )p<0.001. The addition of 
clonidine and neostigmine significantly increased the duration of 
analgesia  but neostigmine caused more nausea 
 MATERIALS AND METHODS 
This study was conducted at the  Chengalpattu Medical College 
Hospital , Chengalpattu - between May 2009  to  August  2009 on 60 
patients of ASA physical status  I and II undergoing   infra umbilical 
surgeries .  
This study was done after Ethical Committee approval and written 
informed consent obtained from all patients included in the study. 
STUDY DESIGN 
This study was done in a prospective double blinded randomized 
manner.  
SELECTION OF CASES 
Inclusion criteria 
- Patients in age group of 20 to 50 yrs . 
-  ASA –PS I & II 
- Infra umbilical surgeries . 
Exclusion criteria 
- ASA –PS III & IV 
- Patient refusal 
 - Renal / hepatic dysfunction 
- Allergy to  drugs 
- Contra indication to sub arachnoid block. 
60 patients were included in this double blinded randomized controlled 
study. patients were divided into 3 groups.  
Patients in group B received  2.75ml of 0.5% hyperbaric bupivacaine   
plus 0.4ml saline.  
Patients in group C1 received 2.75ml  of hyperbaric bupivacaine  with 40 
µg of clonidine  . 
 Patients in group C2 received 2.75ml of hyperbaric bupivacaine  with 
60µg  of clonidine. 
PRE ANAESTHETIC EVALUATION 
Patients included in the study underwent thorough pre operative 
evaluation which included the following 
History 
History of underlying medical illness, previous surgery, 
anaesthesia and hospitalization.  Patients were advised overnight 
starvation. 
  
CLONIDINE & BUPIVACAINE 
 
Physical  examination 
1. GC of the patient 
2. Vital signs 
3. Height and weight 
4. Examination of CVS , RS , CNS  and vertebral columns 
5. Airway assessment 
Investigations 
Hb , PCV, BT, CT, RFT, blood sugar , ECG, CXR , platelet count, 
Blood grouping and cross matching were done.Patients who satisfied the 
inclusion criteria were explained about the nature of the study and the 
anaesthetic procedure. Written informed consent were obtained from all 
patients included in the study. 
 HOW DOUBLE BLINDING WAS DONE  
Allotment of cases was done by computerized lots. The Consultant 
who made the drug combination took no further part in the study. I 
performed the subarachnoid block and made intraoperative observations. 
Postoperatively in the recovery room, observations were done. 
Technique 
In the OT, appropriate equipment for airway management and 
emergency drugs were kept ready. Patient was shifted from 
premedication room to the OT after giving oral diazepam 5mg  2hrs prior 
to  surgery.The horizontal position of the operating table was checked and 
patient shifted to the table  I.V.line was started and intra venous fluids 
started. NIBP, SpO2 , ECG leads were connected to the patient.Pre 
operative baseline systolic and diastolic BP , PR, SpO2  and RR  were 
recorded.  SAB and done and  observations  were  made in all the patients 
involved in the study. Under strict aseptic precautions a  midline lumbar 
puncture was performed using a 24/ 25G Quincke  needle in sitting 
position/right lateral decubitus position. The patient was then immedietly 
placed in supine position.Lumbar puncture was successful  in first 
attempt in almost all patients.The time for intrathecal injection was 
 considered as 0 and the following parameters were observed - sensory 
blockade, motor blockade,  duration of analgesia and sedation. 
 Vital signs and side effects 
The   PR, systolic and diastolic BP,  SpO2  and RR  were recorded 
every min for 5 mins and then every 5 mins throughout the intra operative 
period.The above vital signs at the completion of surgery were noted. 
Hypotension defined as fall in systolic BP > 30  % from baseline or MAP 
<60 mmHg.This was managed with inj. Ephedrine 6mg increments.  
Bradycardia was defined as HR <60 /min and this was managed with 
inj.atropine 0.01mg/kg i.v. 
Respiratory depression defined as RR< 8/min and or SpO2 <85%.This 
was planned to be managed with bag and mask ventilation or intubation 
and IPPV if necessary. Blood loss more than the allowable loss was 
replaced  with blood. The occurrence of sedation were assessed using 
Ramsay sedation scale 
Assessment in Recovery Room 
Patient was shifted to recovery room after completion of surgery, 
the vital signs were recorded, every 15 mins in the 1st hr after surgery and 
30 mins interval for next 2 hrs and thereafter at hourly intervals for next 3 
 hrs. Sensory and motor block assessment were done every 15 mins till 
recovery of pin prick sensation to L1 and BROMAGE score of 1 
respectively. Patients were shifted to post operative ward after complete 
resolution of motor blockade. 
Assessment of pain and duration of analgesia  
     In the recovery room pain assessment using VAS were done every 
15 mins . At the end of surgery, the degree of pain was assessed using 
VAS scale till VAS score >4 was reached. Whenever the patient 
complained of pain and rescue analgesic  Inj. Diclofenac 75mg i.m was 
given. Duration of effective analgesia was defined as time interval 
between onset of SAB and the time to reach VAS >=4. 
Patients were monitored for 24 hrs to detect the occurence of   side 
effects - respiratory depression, nausea, vomiting ,dry mouth and pruritis. 
Patients were also enquired about the occurence of Transient neurological 
symptoms which was described as pain / paresthesia in the neck, 
buttocks, legs or pain radiating to lower extremities after initial recovery 
from SAB  within    72 hrs. 
 
 OBSERVATIONS & RESULTS 
STATISTICAL ANALYSIS: 
All recorded data were entered using  MS Excel software and 
analysed using STATA software for determining the statistical 
significance.  Analysis of Variance was used to study the significance of 
mean of various study parameters between the three groups. Student’s t 
test was used to compare the two groups on mean values of various 
parameters. The p-value taken for significance is 0.05.  
DEMOGRAPHICS: 
1.DISTRIBUTION OF MEAN AGE BY GROUPS 
PARAMETERS GROUP B GROUP C1 GROUP C2 p- VALUE 
No. Of cases 20 20 20 
Mean 38.5 35.25 36.25 
S.D 8.6 8.84 9.49 
0.5075 
 
 2. DISTRIBUTION OF MEAN HEIGHT (cms)  BY GROUPS 
PARAMETERS GROUP B GROUP C1 GROUP C2 p- VALUE 
No. Of cases 20 20 20 
Mean 160.4 166 167.5 
S.D 4.0574 5.5345 7.3592 
0.001 
 
3. DISTRIBUTION OF MEAN WEIGHT (Kgs) BY GROUPS 
PARAMETERS GROUP B GROUP C1 GROUP C2 p-VALUE 
No. Of cases 20 20 20 
Mean 56.5 62.2 65.1 
S.D 5.9338 8.3766 6.3526 
0.299 
 
The groups were comparable with respect to their age and weight. 
There is difference among groups with regard to height, it may be due to 
less sample size. 
 4. DURATION OF SURGERY 
PARAMETERS GROUP B GROUP C1 GROUP C2 p-VALUE 
No. Of cases 20 20 20 
Mean 100.5 118.5 99.5 
S.D 39.53 45.11 33.64 
0.24 
  
The mean duration of surgery is higher in Group-C1 compared to 
other two groups and Group-C2 has lower mean duration. However, there 
is no statistical significance among the groups. 
5. TYPE OF SURGERY BY GROUPS 
SURGERY GROUP B GROUP C1 GROUP C2 
# Both bones leg 2 4 3 
DHS 3 2 3 
Inguinal hernia 4 3 4 
Epigastric hernia 1 - 2 
# SOF 2 3 4 
Appendicectomy 3 2 3 
Implant exit 2 1 1 
Diagnostic arthroscopy 3 3 - 
Knee arthroplasty - 1 - 
 
 6. DISTRIBUTION OF MEAN ONSET OF SENSORY BLOCK 
(secs) BY GROUPS 
PARAMETERS GROUP B GROUP C1 GROUP C2 p-VALUE 
No. Of cases 20 20 20 
Mean 103 177.25 156.25 
S.D 10.809 43.542 32.23577 
0.001 
 
ONSET OF SENSORY BLOCK 
 
There is a significant difference between groups with regard to 
onset of sensory block ,with group C2  having a rapid onset compared to 
C1. 
 7. DISTRIBUTION OF MEAN ONSET OF MOTOR BLOCK 
(secs) BY GROUPS 
PARAMETERS GROUP B GROUP C1 GROUP C2 p-VALUE 
No. Of cases 20 20 20 
Mean 177.25 199 193.150 
S.D 18.6007 15.61 11.663 
0.001 
 
ONSET OF MOTOR BLOCK 
 
There is significant difference between groups in the onset of 
motor block.Group C2  has a faster onset compared to C1. 
 8. DISTRIBUTION  OF MAX. SENSORY BLOCK AMONG 
 GROUPS 
PARAMETERS GROUP B GROUP C1 GROUP C2 
 NO % NO % NO % 
T4 0 0 6 30 10 50 
T5 1 5 1 5 0 0 
T6 10 50 9 45 10 50 
T8 9 45 4 20 0 0 
Maximum  sensory block of T4  was observed in 50% of cases in group 
C2  and 30% of cases in group C1 
9. DISTRIBUTION  OF CASE BY GROUPS  AND GRADE OF 
 MAXIMUM MOTOR BLOCK 
PARAMETERS GROUP B GROUP C1 GROUP C2 p-VALUE 
No. Of cases 20 20 20 
Mean 4 4 4 
S.D 0 0 0 
 
 
There is no difference between the groups in the grade of 
maximum motor block. 
 10. DISTRIBUTION OF MEAN TWO SEGMENTAL 
 REGRESSION(mins) BY GROUPS 
PARAMETERS GROUP B GROUP C1 GROUP C2 p-VALUE 
No. Of cases 20 20 20 
Mean 128 187.05 211 
S.D 16.091 8.846 21.250 
0.001 
 
 
There is significant difference between groups  in two segment 
regression –with C2 having a much longer time    compared  to C1. 
 
11. DISTRIBUTION OF MEAN DURATION OF MOTOR 
BLOCK(mins ) BY GROUPS 
 
PARAMETERS GROUP B GROUP C1 GROUP C2 p-VALUE 
No. Of cases 20 20 20 
Mean 188.75 263.25 284.5 
S.D 13.848 12.904 16.693 
0.001 
 
 
 DURATION OF MOTOR BLOCK 
 
There is significant difference between groups in duration of motor 
block with group C2 having longer duration compared to C1. 
12. DISTRIBUTION OF MEAN DURATION OF ANALGESIA 
 BY GROUPS 
PARAMETERS GROUP B GROUP C1 GROUP C2 p-VALUE 
No. Of cases 20 20 20 
Mean 219.25 305.75 314 
S.D 9.215 17.341 28.635 
0.001 
 
 DURATION OF ANALGESIA 
 
There is significant difference between groups in total duration of 
analgesia with C2  having a much longer duration compared to C1. 
DISTRIBUTION OF MEAN ARTERIAL PRESSURE AMONG 
THE GROUPS 
 
 
 DISTRIBUTION OF HR AMONG GROUPS 
 
DISTRIBUTION OF SBP 
 
 DISTRIBUTION OF DBP 
 
 
There is no statistically significant difference among groups 
with respect to hemodynamics 
DISTRIBUTION OF SIDE EFFECTS 
EFFECTS GROUP B GROUP C1 GROUP C2 
 NO % NO % NO % 
HYPOTENSION 2 10 1 5 2 10 
BRADYCARDIA 1 5 1 5 2 10 
SEDATION 0 0 10 50 20 100 
DRYNESS OF 
MOUTH 
0 0 1 5 2 10 
 DISCUSSION 
Alpha 2 agonist  clonidine  added  to local anaesthetics  have been  
shown to  provide excellent surgical anaesthesia. 
ONSET OF SENSORY BLOCK: 
      The mean time to onset of sensory block was 103secs in control 
group. It is 177.25secs in group C1 and 156.25secs in group C2 . Onset 
time  is statistically significantly prolonged in group C1 
Klimscha et al23  studied intrathecally administered 0.5% 
bupivacaine  5mg and 150µg clonidine   vs plain bupivacaine  and 
showed there is no statistically significant difference between the groups. 
ONSET OF MOTOR BLOCK : 
     The mean time to onset of motor block was 177 secs in control 
group . it was 199secs in group C1  and 193 secs in group C2. There is no 
statistically significant diference  among the three groups . 
This correlated with the study by Acalvoschi lurie et al1   who 
found that addition of clonidine 2µg /kg  with 1mg/kg meperidine  
intrathecally  had no significant difference  compared to meperidine with 
epinephrine 200µg in the onset of motor blockade. 
 MAXIMUM LEVEL OF SENSORY BLOCK: 
There was no statistically significant difference among the groups  
in maximum level of sensory block. 
        De kock et al9 in his study found that addition of intrathecal 
clonidine in increasing doses (15µg, 45µg, 75µg) with 8mg of 
ropivacaine  increased the level of sensory block as the dose of clonidine 
increases. 
MAXIMUM LEVEL OF MOTOR BLOCK: 
The  median of  maximum grade of motor block  measured using 
modified bromage scale was grade 4 in all the groups. There is no 
statistically significant difference  among the two groups. 
          Klimscha et al23 showed that intrathecal clonidine 150µg added to 
0.5% bupivacaine significantly increased the intensity of motor block. 
          Bonnet et al3 in his study found that intensity and duration of motor 
block  was prolonged with increasing the dose of clonidine from 75µg  to 
150µg added to 0.5% tetracaine 15mg. 
 TIME FOR TWO SEGMENTAL  REGRESSION: 
The mean time taken for two segmental regression was 211mins in 
group C2  compared to 187.05 mins in group C1. group C2 had 
significantly prolonged time for two segmental regression  compared to 
C1. 
         This correlated with the study by Fogarty et al15 that addition of 
75µg of clonidine  with 2.75ml of 0.5%  hyperbaric bupivacaine  
prolonged the time to two segment regression  below L4 by 216+/- 97.1 
mins compared with control of 138+/-59.9  mins. 
     Fakuda et al16 found in their study that time to two segment 
regression of sensory block was significantly prolonged when clonidine 
150µg was added to 0.5% tetracaine compared with 0.5% tetracaine 
alone. 
MEAN DURATION OF MOTOR BLOCK : 
The mean duration of motor block was 263 mins in group C1  
compared to 284mins in group C2. This was statistically significant . 
         This correlated with the study by Dobrydnjov et al 11 where 
clonidine combined with small dose bupivacaine during subarachnoid 
 block for inguinal hernioraphy  prolonged the duration of motor block 
compared to bupivacaine alone. 
Study by Bonnet F et al4 compared the  effects of oral and 
subarachnoid clonidine on spinal anaesthesia with bupivacaine  showed 
prolongation of motor block (175+/- 68mins) with spinal clonidine 
compared to oral clonidine (103±20mins) . 
MEAN DURATION OF ANALGESA 
The mean duration of analgesia was 305 mins in group C1     
compared to 314 mins in group C2. The difference is statistically 
significant  when compared with control group B. 
This correlated with study by Stephen strebel33 where he studied  
small dose intrathecal  clonidine and isobaric bupivacaine for orthopaedic 
surgeries. There was significant prolongation of analgesia compared to 
control group. 
Dobrydnjov   et al11 also showed in his study that clonidine added  
to small dose bupivacaine  for inguinal hernioraphy had prolonged 
analgesia compared to control group. 
 Gautier et al20  showed in study that clonidine combined  with 
sufentanil  for  first stage of labour significantly prolonged analgesia 
compared with sufentanil alone. 
Study by Mercier et al27 showed addition of clonidine to intrathecal 
sufentanil for labour  significantly prolonged analgesia. 
 
 Complications 
Study by Chiari Astrid et al7  on analgesic and hemodynamic 
effects of intrathecal clonidine as a sole analgesic agent during 1st stage of 
labour  showed hypotension was produced with increasing doses of 
clonidine. 
Study by  Filos kriton et al14  found that hypotension is the main 
side effect. 
Studies done by Freedman JM et al17  and Hampl KF et al22 showed 
an increased occurrence of TNS in patients undergoing spinal anaesthesia 
with lignocaine. 
In our study ,patients in both clonidine groups  had sedation with 
RSS score ≤ 3 , which did not require any active intervention. 
With respect to  hemodynamic parameters , incidence of 
bradycardia and hypotension  were not significantly higher in  clonidine 
groups compared to control group.Hypotension    and  bradycardia were 
observed in   5-10% of patients in clonidine  group. 
Hypotension was treated with ephedrine and bradycardia with 
atropine  
 
 CONCLUSION 
In conclusion the addition of clonidine as an adjuvant to 
bupivacaine in subarachnoid block prolongs duration of both sensory and 
motor block. 
I conclude that 60µg of clonidine  hydrochloride added to local 
anaesthetic in subarachnoid block has proved to be a better adjuvant  in 
prolonging  the sensory and motor  blockade intra operatively  and 
duration of effective post operative analgesia  compared to 40µg , without 
significant adverse effects. 
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 PROFORMA 
Name  : 
Age /sex 
Duration of surgery                                                    
    ASA  HEIGHT  WEIGHT 
     
Pre op  assessment  
 
Airway  
 
Drug  therapy  
INVESTIGATIONS  
Hb  PCV  BT  CT  RBS  CREAT  PLATELETS 
             
 
 
MONITORS 
                                                                                        
  IV ACCESS  PRELOADING 
   
ECG  NIBP  SPO2  TEMP 
                                
                                                                                  
SAB 
SPACE  NEEDLE  SIZE  APPROACH/  POSITION  GROUP  
         
 
BLOCK  CHARACTERISTICS    
TIME  1”  3”  5”  8”  10”  15”  30”  60”  1Hr 
30” 
Motor  
 
                 
Sensory 
 
                 
Vas 
score 
                 
  
INTRA OP FLUIDS  
INTRA OP BLOOD LOSS 
 
INTRA OP  HEMODYNAMICS  
 
TIME  1”  3’’  5’’  10”  15”  30”  45”  60”  1hr30” 
HR                   
SBP                   
DBP                   
MAP                   
SPO2                   
RR                   
 
POST OP  
Time  for demand of analgesia 
Total duration of post op analgesia 
PERIOPERATIVE  COMPLICATIONS 
  INTRA OP  POST OP  TREATMENT DETAILS 
EXCESS SEDATION       
HYPOTENSION       
RESP DEPRESSION       
BRADYCARDIA       
URINARY RETENTION       
SHIVERING       
NAUSEA, VOMITING       
HEADACHE       
CONFUSION       
ANXIETY       
NEUROLOGICAL       
OTHERS       
 
S.No HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP
1 76 124 80 95 88 123 78 93 88 100 62 75
2 86 110 76 87 90 98 58 71 92 100 60 73
3 82 120 70 87 86 120 70 87 90 130 70 94
4 82 130 90 103 84 126 88 101 92 120 80 93
5 82 110 80 90 84 112 80 91 80 112 80 91
6 68 110 70 83 68 110 70 83 64 110 64 79
7 82 120 74 89 78 120 72 88 78 116 70 85
8 80 120 82 95 82 120 80 93 80 120 80 93
9 78 110 80 90 68 110 80 90 68 114 80 90
10 66 110 74 86 64 110 70 83 62 106 70 82
11 84 126 80 95 84 126 80 95 76 110 64 79
12 97 117 80 93 100 114 80 91 98 110 72 82
13 72 126 80 95 72 110 70 83 76 110 64 79
14 94 130 80 97 92 104 60 75 92 104 60 75
15 84 118 74 89 92 117 70 86 98 118 74 89
16 74 110 70 83 74 110 70 83 72 106 70 82
17 100 120 80 93 102 120 80 93 100 120 80 93
18 90 137 86 103 82 122 76 91 84 116 67 83
19 74 110 70 83 78 102 68 79 80 102 68 78
20 84 114 80 91 91 120 80 93 80 114 86 95
BASE LINE 5 MIN 10 MIN
HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP HR 
78 101 66 78 74 104 66 79 78 100 70 80 78
90 102 62 75 90 102 64 77 90 110 70 83 88
82 130 70 83 84 130 70 83 86 108 60 76 96
90 118 76 90 78 118 74 89 76 116 72 87 74
82 112 80 91 82 110 70 83 84 110 80 90 84
58 110 68 82 60 110 70 83 64 126 78 94 64
80 116 68 84 76 120 70 87 78 120 70 83 80
84 122 80 94 82 120 80 93 84 110 80 90 86
62 112 80 91 66 110 80 90 64 112 80 91 58
68 102 64 77 62 106 54 71 64 110 77 88 60
74 100 60 73 72 92 60 71 78 100 80 87 74
96 106 72 83 96 100 70 80 97 94 65 75 78
74 100 60 73 72 92 60 71 68 96 60 72 74
94 704 66 79 92 100 66 77 96 106 48 67 96
90 120 58 79 98 94 43 60 100 116 72 87 116
72 100 76 84 76 100 74 83 72 100 74 83 76
88 100 72 81 88 90 70 77 88 90 70 77 92
82 108 64 79 92 109 64 79 90 101 59 83 83
88 100 68 79 90 100 64 76 92 88 66 73 98
78 112 70 81 76 114 74 87 68 110 74 86 62
15 MIN 20 MIN 25 MIN
SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP
100 70 80 70 100 70 80 74 106 70 82 86 100
110 70 83 86 112 72 85 80 110 58 75 76 112
90 60 70 106 110 70 83 92 120 70 87 86 110
114 70 85 78 116 72 87 74 120 70 87 68 114
90 56 67 82 110 80 90 84 110 56 74 82 96
126 78 94 72 120 70 87 68 100 80 97 60 116
120 74 90 72 116 72 84 68 108 68 81 68 110
114 74 87 82 120 80 93 82 110 80 93 80 113
114 76 89 60 120 70 87 58 120 68 85 60 110
114 70 85 62 110 70 83 70 99 62 75 64 103
104 80 88 60 104 80 88 56 90 70 77 52 110
91 65 74 82 92 62 72 82 91 64 73 73 91
112 60 77 66 114 60 78 62 110 60 77 60 90
106 50 69 92 94 53 67 90 110 62 78 93 93
116 67 83 110 114 73 87 92 110 62 78 93 108
100 74 83 78 102 74 84 72 100 74 83 64 96
80 64 69 92 70 62 65 90 70 62 65 64 90
109 64 79 86 108 68 81 82 116 66 83 90 101
90 60 70 100 94 68 77 77 100 100 68 90 104
110 74 86 70 112 74 87 76 114 76 85 78 114
35 MIN 45 MIN
GROUP B
30 MIN 60 M
DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP
67 78 92 99 66 77 78 106 78 88 78 106 70
68 83 80 112 68 83 88 110 70 83 83 112 72
70 83 86 110 70 83 88 110 70 83 86 120 74
72 86 62 110 72 85 68 116 74 88 64 104 68
58 71 78 110 64 79 84 110 62 78 80 110 60
74 88 66 120 70 87 64 128 74 92 66 126 70
68 82 66 114 70 85 68 116 70 85 70 120 76
74 87 78 116 62 80 80 110 68 82 86 100 64
62 78 64 110 62 78 58 110 70 83 64 110 70
66 78 62 101 66 79 74 95 64 74 66 107 74
72 85 49 100 70 80 52 106 70 82 70 96 70
64 73 92 116 72 87 76 76 62 93 100 92 66
50 63 68 90 60 70 80 100 60 73 90 102 60
48 63 88 109 63 78 86 106 67 80 82 106 73
65 79 82 100 56 71 88 99 56 70 89 94 57
74 81 60 96 74 81 62 100 70 80 80 84 60
58 69 64 90 52 65 72 90 50 65 70 106 55
54 70 74 97 56 70 68 101 58 69 68 98 53
70 66 88 104 74 84 84 106 70 82 82 102 68
74 87 76 112 70 84 68 402 70 81 72 106 64
UP B
MIN 75 MIN 90 MIN 120 MIN
MAP HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP
82 76 110 76 87 80 106 70 82 90 110 70 83
85 82 110 70 83 78 110 64 79 80 110 68 82
89 86 126 76 93 84 120 70 87 88 130 74 93
80 72 108 68 81 30 112 72 85 76 112 72 85
77 86 404 68 80 82 110 74 86 82 112 76 88
89 68 116 74 88 68 110 70 83 66 114 70 85
91 70 108 70 83 72 116 70 85 68 106 68 81
76 86 112 68 83 80 106 64 78 84 114 70 85
83 60 108 70 83 60 112 74 87 62 106 70 82
85 64 110 70 80 76 116 76 89 86 119 72 88
79 68 96 70 79 72 100 76 84 72 100 74 83
75 106 92 64 73 90 92 64 73 88 92 68 76
74 88 100 64 76 86 100 60 73 74 102 74 84
84 80 109 67 81 84 103 69 80 88 109 64 79
68 86 98 70 79 84 100 70 81 82 112 80 91
68 76 90 60 70 72 100 74 83 74 109 63 78
73 70 106 54 71 70 100 55 70 74 110 73 83
68 76 98 58 71 78 100 60 73 68 101 58 73
79 88 114 74 87 86 100 70 80 88 100 70 80
78 76 112 64 80 74 110 74 86 76 106 70 82
150 MIN 180 MIN
UP B
210 MIN
HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP
76 98 72 81 80 110 76 86 84 110 70 83
82 110 64 79 88 106 72 82 88 112 72 85
84 110 74 86 84 126 78 94 86 120 74 84
74 106 74 82 78 112 68 83 74 114 74 87
86 110 74 86 84 112 70 84 85 110 74 86
74 126 78 89 76 120 74 89 70 120 80 93
66 114 70 85 66 114 70 85 70 108 73 84
80 112 70 84 84 110 68 82 84 114 74 87
64 112 70 84 68 110 70 83 60 116 74 88
82 120 74 89 82 120 74 89 82 110 72 85
70 94 70 78 70 110 72 85 74 110 74 85
90 94 70 78 96 92 64 73 98 92 68 76
74 102 74 84 92 90 60 70 74 100 70 80
86 101 64 76 82 110 64 79 80 106 60 75
180 116 80 93 78 106 72 83 78 110 70 83
78 110 74 83 78 110 83 83 74 110 86 86
74 110 73 83 74 100 80 90 76 110 80 90
78 91 55 67 72 99 61 74 74 101 56 71
92 112 64 80 92 106 70 82 88 110 72 85
78 112 70 84 68 106 70 84 70 112 74 87
UP B
240 MN 270 MIN 300 MIN
S.No HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP
1 80 110 70 83 90 96 58 71 92 100 60 73
2 92 110 70 83 90 96 58 71 92 100 60 73
3 80 120 82 95 82 122 80 94 82 122 80 94
4 91 125 80 95 82 123 78 93 88 101 63 76
5 98 116 80 92 96 116 78 91 91 100 67 78
6 82 120 74 89 78 120 72 88 78 116 70 85
7 90 130 80 97 96 130 80 97 96 130 78 95
8 89 120 70 87 86 120 70 81 90 130 70 90
9 78 126 82 97 80 126 80 97 86 126 82 97
10 72 100 78 82 78 102 68 79 90 102 68 79
11 98 110 80 90 96 116 70 86 100 110 70 83
12 76 124 80 95 88 123 78 93 88 100 62 75
13 80 110 70 83 90 96 58 71 92 100 60 73
14 70 110 70 83 74 110 70 83 68 100 70 87
15 90 110 80 90 68 112 82 92 68 114 80 91
16 82 110 80 90 84 112 80 91 84 112 80 91
17 68 100 70 80 72 110 70 83 60 110 70 83
18 82 130 90 103 84 126 88 101 88 124 82 96
19 70 106 70 82 86 102 68 81 90 102 68 81
20 80 126 88 101 80 120 80 93 82 126 82 97
BASE LINE 5 MIN 10 MIN
HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP HR 
90 102 62 75 90 102 64 77 96 106 66 79 92
84 120 84 96 90 102 67 79 80 122 80 94 82
84 120 84 96 80 120 80 94 80 122 80 94 82
102 100 67 78 70 98 68 78 76 107 75 86 76
100 108 74 86 98 90 65 74 98 90 65 75 90
80 116 68 84 76 120 70 87 78 120 70 87 74
92 130 76 94 84 130 70 90 86 108 60 76 98
82 130 70 90 84 130 70 90 86 108 60 76 98
82 122 78 93 88 122 78 93 92 120 78 92 88
90 100 66 77 92 100 66 77 92 100 64 76 96
102 100 68 79 98 98 64 75 96 94 64 74 100
78 101 6 78 74 104 66 79 78 98 62 74 70
90 110 60 77 90 102 68 81 96 100 68 81 92
66 124 70 88 68 112 76 88 66 112 70 84 68
62 112 80 91 60 100 80 87 60 112 80 91 56
82 110 80 90 82 112 80 91 82 110 80 90 82
62 110 68 72 58 110 88 72 58 110 88 87 65
84 126 88 91 90 122 84 97 92 120 80 93 92
92 100 66 79 86 85 56 66 98 90 60 90 102
88 120 78 92 120 120 82 95 88 116 76 89 88
15 MIN 20 MIN 25 MIN
SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP
108 66 80 86 110 70 83 80 112 64 80 82 110
120 80 94 82 120 80 93 82 96 48 64 86 106
120 83 93 82 120 80 93 82 96 48 64 86 106
100 70 80 73 99 70 80 83 117 76 90 81 106
95 65 75 100 99 66 77 100 100 66 77 100 100
116 72 87 68 106 68 81 66 110 70 82 68 110
90 60 70 82 130 70 90 78 110 76 87 86 120
90 60 70 110 130 70 90 88 110 70 83 88 110
128 82 95 88 120 80 93 78 116 74 88 70 119
88 56 67 100 98 66 77 96 102 70 81 90 104
96 76 83 100 100 66 77 98 100 62 75 92 100
100 70 80 74 106 70 82 86 100 67 78 92 99
108 66 80 88 114 74 87 86 112 50 75 88 106
106 70 82 74 102 64 77 70 106 68 81 68 128
110 80 90 52 120 68 85 52 110 62 78 52 110
110 80 90 84 80 50 60 84 110 80 90 80 110
126 78 94 70 130 90 103 64 124 78 93 62 126
118 76 90 74 114 76 89 82 118 74 89 82 118
94 62 73 98 100 65 77 88 104 70 81 88 104
118 76 90 70 120 70 87 72 110 70 83 98 116
GROUP C1
30 MIN 45 MIN 60 MIN 75M
DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP
64 80 78 102 60 74 76 110 64 80 80 114 68
62 77 80 113 74 87 80 110 64 81 80 112 76
62 77 84 106 62 77 78 116 64 81 80 112 76
73 84 86 100 68 79 69 114 70 85 84 112 68
68 79 82 100 72 82 86 100 72 82 88 110 76
66 81 68 120 76 91 68 110 66 81 80 104 74
74 89 88 114 68 83 88 114 68 83 88 114 70
70 83 84 100 74 83 83 110 70 83 88 110 58
74 89 70 119 80 93 80 130 88 102 76 110 76
70 81 88 104 70 81 88 104 70 81 88 114 70
70 80 88 100 70 80 92 100 77 75 88 110 58
66 77 78 108 78 88 74 110 80 83 76 110 76
64 78 76 110 64 70 80 106 70 82 84 114 70
80 96 68 112 74 87 72 114 74 87 76 112 70
60 77 56 110 68 82 54 110 70 83 50 110 70
80 90 80 80 56 60 84 110 82 91 80 80 58
76 93 64 128 72 89 66 126 70 89 68 114 76
74 89 60 114 72 86 68 114 72 77 68 116 74
70 81 86 104 70 81 88 114 70 85 86 100 70
74 88 78 110 68 85 81 110 70 83 80 104 74
MIN 90 MIN 120 MIN 150 MIN
MAP HR  SBP DBP MAP HR  SBP DBP MAP HR  SBP DBP MAP
83 82 112 64 80 88 110 70 83 86 106 70 82
88 88 110 68 82 82 112 68 83 86 106 64 78
88 88 110 68 82 82 112 68 83 86 106 64 78
83 78 106 68 81 76 112 74 87 78 116 70 85
82 88 106 64 78 90 106 62 77 88 110 58 75
84 88 110 74 86 78 106 70 82 74 112 68 83
85 86 104 70 81 90 100 70 80 90 112 60 77
75 90 114 64 81 90 116 68 84 92 110 64 79
87 80 106 74 85 90 110 70 83 76 98 72 81
85 56 104 70 71 90 100 70 80 90 112 60 77
75 90 114 64 81 90 116 68 84 92 110 64 79
87 80 106 74 85 90 110 70 83 76 98 72 81
82 88 110 70 83 92 108 66 80 96 102 64 77
84 78 104 60 75 72 112 70 84 76 112 70 84
83 58 112 70 84 56 110 70 83 50 108 70 83
65 82 110 68 82 84 100 80 90 86 110 62 78
89 66 114 76 89 68 120 68 85 68 116 70 85
88 62 110 70 83 64 108 68 81 70 114 74 87
80 88 100 70 80 92 112 68 83 92 106 70 82
84 88 110 74 86 78 106 70 82 74 112 68 83
240 MN180 MIN 210 MIN
HR  SBP DBP MAP HR  SBP DBP MAP
84 116 70 85 86 112 72 85
86 112 68 83 82 106 64 78
86 112 68 83 82 116 62 80
74 112 70 84 76 111 76 88
90 114 64 81 90 116 68 84
83 110 72 85 78 112 64 80
92 106 72 82 90 110 74 87
84 110 64 78 90 110 74 86
80 110 76 87 82 110 74 87
92 106 70 82 90 112 74 87
84 110 62 78 88 100 74 83
80 110 76 87 84 110 70 83
86 112 68 83 86 112 56 75
78 120 70 87 72 110 70 83
60 112 64 80 62 112 70 84
82 110 74 86 86 110 74 86
66 114 70 85 68 126 78 94
72 108 68 81 70 110 64 79
92 114 74 87 92 110 70 83
78 110 72 85 72 110 72 85
270 MIN 300 MIN
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1 sundarajan 35 m 120 c1 4 t8 2 130 185 190 270 270
2 harish 45 m 100 c1 4 t5 1 230 220 180 260 300
3 tatchiyammal 35 f 140 c1 4 t4 2 120 180 170 240 300
4 elangovan 34 m 60 c1 4 t4 2 150 195 180 270 320 Hypotension
5 shanti 40 f 120 c1 4 t4 2 230 200 180 265 280
6 prakash 20 m 60 c1 4 t4 2 140 195 196 250 300
7 eluamlai 45 m 50 c1 4 t4 2 150 200 185 265 300
8 kanaan 45 m 75 c1 4 t8 2 145 190 180 250 310
9 durai 25 m 70 c1 4 t4 2 200 210 200 270 340
10 kuppan 24 m 150 c1 4 t6 1 230 200 185 250 290
11 thangalelu 50 m 150 c1 4 t6 1 200 210 200 250 280
12 jayanmani 32 m 190 c1 4 t6 1 125 185 180 250 310
13 thyagu 26 m 150 c1 4 t6 1 230 210 200 280 320 Bradycardia
14 radha 26 f 90 c1 4 t6 1 230 240 200 285 315
15 kathikeyan 25 m 75 c1 4 t6 1 220 210 195 280 315
16 arjunan 40 m 180 c1 4 t6 1 145 195 180 270 330
17 kumaraswamy 35 m 140 c1 4 t6 1 130 190 180 250 320
18 mani 48 m 150 c1 4 T6 1 230 210 190 280 300 Dryness of Mouth
19 palani 35 m 195 c1 4 t8 2 160 175 185 260 300
20 kumari 40 f 105 c1 4 t8 2 150 180 185 270 315
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1 madhavan 36 m 70 B 4 t6 1 100 180 130 180 210
2 venkatesan 50 m 100 B 4 t6 1 100 180 140 200 220
3 mohanavel 46 m 45 B 4 t6 1 120 175 145 180 220
4 anjalatchi 50 f 100 B 4 t6 1 100 180 135 210 230
5 raja 36 m 45 B 4 t6 1 110 200 145 200 230 Hypotension
6 meenakashi 40 f 120 B 4 t6 1 110 190 145 220 235
7 lund mary 36 f 120 B 4 t6 1 110 180 135 180 220
8 agasan 45 m 70 B 4 t6 1 120 200 140 200 230
9 padmanathan 45 m 60 B 4 t6 1 90 170 130 180 215
10 velu 40 m 210 B 4 t6 1 100 280 145 210 200
11 aravind 26 m 140 B 4 t8 1 110 185 150 180 215
12 mani 45 m 135 B 4 t8 1 80 170 110 170 220
13 rajesh 36 m 120 B 4 t8 1 100 180 110 180 220 Hypotension
14 subramani 46 m 105 B 4 t8 1 110 180 110 185 215
15 ravishankar 26 m 70 B 4 t8 1 110 175 115 185 215
16 neelankandan 21 m 80 B 4 t8 1 100 195 115 180 210
17 ramesh 24 m 90 B 4 t8 1 100 175 110 175 230
18 lavanya 38 f 130 B 4 t5 1 110 180 110 180 210
19 ravi 39 m 70 B 4 t8 1 80 160 100 180 210
20 ayyaswamy 45 m 130 B 4 t8 1 100 110 140 200 230
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1 parthasarathy 50 m 120 c2 4 t6 2 135 190 210 300 340
2 venu 28 m 100 c2 4 t6 2 120 196 215 295 350
3 partahasarathy 50 m 120 c2 4 t4 2 160 190 230 290 350
4 mala 36 f 120 c2 4 t4 2 200 190 220 295 355
5 perumal 42 m 60 c2 4 t4 3 150 200 210 290 360 Hypotension
6 ramani 36 f 120 c2 4 t4 3 230 210 240 300 320
7 magala 46 f 70 c2 4 t4 3 140 185 200 280 350
8 sarath 37 m 90 c2 4 t4 3 130 180 140 260 270
9 vijatsarathi 20 m 140 c2 4 t6 2 145 200 210 280 310 Hypotension
10 madhavan 29 m 60 c2 4 t6 2 135 180 190 285 280
11 raja 35 m 60 c2 4 t4 2 140 180 220 260 300
12 murugan 25 m 120 c2 4 t4 2 145 206 215 275 315 Dryness of mouth
13 nithyanandam 22 m 150 c2 4 t6 2 140 200 225 295 315
14 chellamuthu 50 m 120 c2 4 t6 2 145 220 215 275 275
15 gunasekaran 38 m 120 c2 4 t6 2 145 186 230 270 310 Bradycardia
16 marimuthu 45 m 60 c2 4 t4 2 210 190 200 310 290
17 logonathsn 38 m 80 c2 4 t6 2 225 210 190 310 280
18 devbararath 22 m 60 c2 4 t4 2 145 185 230 300 310 Dryness of mouth
19 iniyan 40 m 160 c2 4 t6 1 140 180 220 265 310
20 madhivani 36 f 60 c2 4 t6 1 145 185 210 255 290 Bradycardia
GROUP C2
